{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:40Z","timestamp":1792099600315,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0052776"],"award-info":[{"award-number":["NNF18OC0052776"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF10CC1016517"],"award-info":[{"award-number":["NNF10CC1016517"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF12OC1015920"],"award-info":[{"award-number":["NNF12OC1015920"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0056411"],"award-info":[{"award-number":["NNF19OC0056411"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["9040-00106B"],"award-info":[{"award-number":["9040-00106B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["DFF-9039-00037A"],"award-info":[{"award-number":["DFF-9039-00037A"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MOLIN18G0"],"award-info":[{"award-number":["MOLIN18G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020729","name":"Choquette Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cmi.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:13:37Z","timestamp":1660868017000},"page":"1594-1601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance"],"prefix":"10.1016","volume":"28","author":[{"given":"Lise","family":"Goltermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper Langebjerg","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.08.003_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41579-020-00477-5","article-title":"Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis","volume":"19","author":"Rossi","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2022.08.003_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines","volume":"176","author":"Flume","year":"2012","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.cmi.2022.08.003_bib3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines","volume":"187","author":"Jr.","year":"2013","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.cmi.2022.08.003_bib4","first-page":"145","article-title":"Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis","volume":"58","author":"Nagai","year":"1991","journal-title":"Respiration"},{"key":"10.1016\/j.cmi.2022.08.003_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaff\u00e9","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2022.08.003_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/thx.49.6.531","article-title":"Diffuse panbronchiolitis and cystic fibrosis: east meets West","volume":"49","author":"Hoiby","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2022.08.003_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2004.09.001","article-title":"Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study","volume":"4","author":"Hansen","year":"2005","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cmi.2022.08.003_bib8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","article-title":"Quorum-sensing antagonistic activities of Azithromycin in Pseudomonas aeruginosa PAO1: a global approach","volume":"50","author":"Nalca","year":"2006","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.cmi.2022.08.003_bib9","article-title":"Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution","volume":"9","year":"2003","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.cmi.2022.08.003_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01847-2016","article-title":"Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients","volume":"49","author":"Mustafa","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.08.003_bib11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/cid\/cis473","article-title":"Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability","volume":"55","author":"Buyck","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.08.003_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00333665","article-title":"Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins","volume":"127","author":"Wittmann","year":"1973","journal-title":"Mol Gen Genet Mgg"},{"key":"10.1016\/j.cmi.2022.08.003_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1006\/jmbi.1999.2839","article-title":"Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA","volume":"289","author":"Gregory","year":"1999","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.cmi.2022.08.003_bib14","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/AAC.01011-06","article-title":"Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in cftr\u00a0\u2212\/\u2212 mice","volume":"51","author":"Hoffmann","year":"2007","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.cmi.2022.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003741","article-title":"Genome Analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators","volume":"9","author":"Marvig","year":"2013","journal-title":"Plos Genet"},{"key":"10.1016\/j.cmi.2022.08.003_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ng.3148","article-title":"Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis","volume":"47","author":"Marvig","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2022.08.003_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2022.08.003_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mimet.2005.06.001","article-title":"A\u00a010-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation","volume":"64","author":"Choi","year":"2006","journal-title":"J\u00a0Microbiol Meth"},{"key":"10.1016\/j.cmi.2022.08.003_bib19","doi-asserted-by":"crossref","first-page":"22275","DOI":"10.1073\/pnas.1909831116","article-title":"Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate","volume":"116","author":"Halfon","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cmi.2022.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48685","article-title":"Adaptation of hydroxymethylbutenyl diphosphate reductase enables volatile isoprenoid production","volume":"9","author":"Bongers","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cmi.2022.08.003_bib21","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1038\/s41596-021-00572-8","article-title":"Testing physiologically relevant conditions in minimal inhibitory concentration assays","volume":"16","author":"Belanger","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cmi.2022.08.003_bib22","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/jb.176.20.6192-6198.1994","article-title":"Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli","volume":"176","author":"Chittum","year":"1994","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.cmi.2022.08.003_bib23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1261\/rna.5400703","article-title":"The extended loops of ribosomal proteins L4 and L22 are not required for ribosome assembly or L4-mediated autogenous control","volume":"9","author":"Zengel","year":"2003","journal-title":"Rna"},{"key":"10.1016\/j.cmi.2022.08.003_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1365-2958.2007.05975.x","article-title":"Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli","volume":"66","author":"Zaman","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.cmi.2022.08.003_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jmb.2009.01.037","article-title":"Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and Antibiotics binding","volume":"387","author":"Fulle","year":"2009","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.cmi.2022.08.003_bib26","article-title":"Evolutionary genomics of niche-specific adaptation to the cystic fibrosis lung in Pseudomonas aeruginosa","volume":"38","author":"Dettman","year":"2020","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.cmi.2022.08.003_bib27","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41467-021-23451-y","article-title":"Compensatory evolution of Pseudomonas aeruginosa\u2019s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis","volume":"12","author":"La Rosa","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2022.08.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.05.025","article-title":"Long-term effects of azithromycin in patients with cystic fibrosis","volume":"117","author":"Samson","year":"2016","journal-title":"Resp Med"},{"key":"10.1016\/j.cmi.2022.08.003_bib29","first-page":"67","article-title":"Azithromycin is the answer in paediatric respiratory medicine, but what was the question?","volume":"34","author":"Bush","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.cmi.2022.08.003_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jcf.2016.12.003","article-title":"Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis","volume":"16","author":"Nichols","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cmi.2022.08.003_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1164\/rccm.201906-1206OC","article-title":"Pulmonary outcomes Associated with long-term Azithromycin therapy in cystic fibrosis","volume":"201","author":"Nichols","year":"2019","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.cmi.2022.08.003_bib32","series-title":"GOLD website","article-title":"Global strategy for the diagnosis, management and prevention of COPD, GOLD 2017","year":"2016"},{"key":"10.1016\/j.cmi.2022.08.003_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","article-title":"Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"8","author":"Kobbernagel","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22004190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22004190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:24:01Z","timestamp":1778592241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22004190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1198743X22004190"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.08.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.28.482231","asserted-by":"object"}]},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}